The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,868.00
Bid: 1,854.00
Ask: 1,860.00
Change: 0.00 (0.00%)
Spread: 6.00 (0.324%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

7 Sep 2010 07:01

RNS Number : 2408S
Genus PLC
07 September 2010
 



For immediate release 7 September 2010

 

Genus plc

("Genus" or "the Company")

 

Board Change

 

 

Genus, a leading global animal genetics company, is pleased to announce that Bob Lawson will become non-executive Chairman following the Company's Annual General Meeting on 11 November 2010 when John Hawkins, the present Chairman, will retire from the Board having served ten years as a non-executive director of the Company and six years as Chairman.

 

Bob Lawson, 65, is non-executive Chairman of Barratt Developments plc and is shortly to retire as Chairman of Hays plc. He is also a director of The Federation of Groundwork Trusts. His career has spanned several United Kingdom and continental groups including 10 years as Chief Executive of Electrocomponents plc leading its successful expansion into new international markets and three years as Managing Director of Vitec Group plc.

 

Bob Lawson said:

 

"I am excited at the potential of Genus' opportunities for growth, its world leading technology and the way this technology will be able to help increase food production for an increasing global population."

 

John Hawkins, Chairman, commented:

 

"I joined the Genus Board ten years ago. In that time, Genus has achieved tremendous growth with profits up tenfold. As I approach the end of my second three year term as Chairman, I have decided that the time is right for me to hand over leadership of the Board as Genus enters its next exciting phase of growth. Following an external search, I am pleased that Bob Lawson has accepted the Board's invitation to succeed me as Chairman from the conclusion of this year's Annual General Meeting. Bob has excellent experience in international markets and in chairing major companies and I wish him and Genus every success in the future.

 

I look back with pride on what Genus has achieved over the last ten years and I am certain the business will go from strength to strength in the years ahead."

 

Richard Wood, Chief Executive, said:

 

"On behalf of the Board, I would like to thank John for his considerable contribution over his ten years with Genus. John has overseen a transformation of the Company from its original flotation on AIM to becoming a truly global FTSE250 company and he has been instrumental in the expansion of Genus worldwide."

 

"I am delighted to welcome Bob Lawson to Genus. He will bring substantial experience to the Board, particularly in international markets. I look forward to working with him as we continue our strategic focus on growth in both developed and the developing markets."

 

Bob Lawson will chair the Company's Nomination Committee and be a member of the Company's Remuneration Committee. No further information is required to be disclosed in relation to Bob Lawson pursuant to LR 9.6.13 R.

 

For further information please contact:

Genus plc

Tel: 01256 345970

John Hawkins, Chairman

Richard Wood, Chief Executive

Buchanan Communications

Tel: 020 7466 5000

Charles Ryland, Suzanne Brocks

 

 

About Genus

 

Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors.

 

Genus' worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality, and use these to supply the global dairy and meat supply chain.

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network.

 

Headquartered in Basingstoke, England, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGGLVVVGGZM
Date   Source Headline
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings
5th Jun 20239:12 amRNSAdditional Listing
24th May 20234:54 pmRNSNotification of Major Holdings
18th May 20231:32 pmRNSDirector/PDMR Shareholding
16th May 20236:16 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSTrading Update
9th May 20234:30 pmRNSNotification of Major Holdings
3rd May 20238:44 amRNSTotal Voting Rights
2nd May 20237:00 amRNSShare Award for Incoming CEO
3rd Apr 202311:27 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSAppointment of Chief Executive Officer Designate
21st Mar 20232:58 pmRNSApplication for Block Listing
6th Mar 202312:53 pmRNSNotification of Major Holdings
2nd Mar 20231:51 pmRNSNotification of Major Holdings
1st Mar 20232:20 pmRNSNotification of Major Holdings
24th Feb 20235:13 pmRNSDirector/PDMR Shareholding
24th Feb 202311:39 amRNSNotification of Major Holdings
23rd Feb 20239:33 amRNSReplacement: Interim Results
23rd Feb 20237:00 amRNSChief Executive Officer Retirement
23rd Feb 20237:00 amRNSInterim Results
21st Feb 20235:03 pmRNSNotification of Major Holdings
10th Feb 20232:08 pmRNSNotification of Major Holdings
1st Feb 202310:00 amRNSBlock listing Interim Review
23rd Nov 20221:02 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.